Winners

2025

Dr. Julia Zhuravleva, hematologist, R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg

Outcomes of allogeneic hematopoietic stem cell transplantation in high-risk chronic lymphocytic leukemia patients

Dr. Anastasia Vasilieva, hematologist, Ph.D, Outpatient Department of Oncology and Chemotherapy of hemoblastoses and depressions of hematopoiesis, National Research Center for Hematology, Moscow

Significance of mutations in ASXL1 and DNMT3A genes in patients with acute T-cell lymphoblastic leukemia/lymphoma

Dr. Yuliya Yakovleva, hematologist, R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg

The Outcomes of Patients with Blast Crisis Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

Dr. Marat Mingalimov, City Clinical Hospital no. 52, Assistant professor Hematology Department, Sechenov University, Moscow.

Molecularly-adapted therapy for untreated diffuse large B-cell lymphoma

Dr. Nikita Shorokhov, Hematologist, Department of Hematology and Chemotherapy with Bone Marrow and Hematopoietic Stem Cell Transplantation Unit, N. I. Pirogov National Medical and Surgical Center, Moscow

Prospective Multicenter Study on the Effectiveness and Safety of PET-Adapted Treatment for Patients with Newly Diagnosed Classical Hodgkin Lymphoma Using ABVD and EACODD-14 Chemotherapy Regimens (HL-Russia-1)

Dr. Nikita Levkovsky, R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg

Features of acute steroid-refractory graft-versus-host disease therapy with ruxolitinib in children

2024

Dr. Alexina Shatilova, junior researcher of the Immuno-oncology Research Institute of the Research Centre for Personalised Oncology of the National Centre for Personalised Medicine of the Almazov National Medical Centre, St. Petersburg.

Acute myeloid leukemia with mutations in epigenetic modifiers: molecular features and prognosis

Dr. Tuyara Aleksandrova, hematologist, Haematology Department, Republican Hospital No. 1 – National Centre of Medicine named after M.E. M.E. Kuznetsov, St. Petersburg

The role of aberrant cytokine secretion in tyrosine kinase treatment failure in patients with chronic myeloid leukemia

Dr. Anastasia Popova, 2nd year resident in haematology at N.I. Pirogov Russian National Medical University, Moscow;

Long-term results of targeted therapy for myelofibrosis at the Moscow Hematology Center predictors of treatment efficacy

Dr. Maria Sannikova, haematologist, outpatient department of hematology, oncology and chemotherapy, Botkin Hospital, Moscow.

Comparison of the effectiveness of RB and R-CHOP regimens in first-line therapy in 277 patients with grade I-II follicular lymphoma: a retrospective single-center analysis

Dr. Polina Kotselyabina, 2nd year resident in haematology at the R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg

Allogeneic hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome: a 10-year matched retrospective cohort study

2023

Dr. Yulia Rogacheva, postgraduate student of the Department of Hematology, Transfusiology and Transplantology with a course of pediatric oncology NA Professor B.V. Afanasiev, Research Institute of Pediatric Oncology, PSPbGMU named after Acad. I.P. Pavlov, St. Petersburg.

“De-escalation approach to therapy of febrile neutropenia in patients colonized with carbapenem-resistant strains during allogeneic bone marrow transplantation”.

Dr. Maxim Granatkin, hematologist, postgraduate student of the Department of Hematology and Transfusiology, RMACPE, hematologist at the Botkin State Clinical Hospital.

“Combination of hypomethylating agents with bcl-2 inhibitors in the treatment of relapsed acute myeloid leukemia”.

Dr. Alena Dorofeeva, researcher of the laboratory of physiology of hematopoiesis, National medical research center for hematology of the Ministry of Health of Russia, Moscow.

“Blood serum of patients with aplastic anemia inhibits the growth of bone marrow stromal cells of healthy donors”.

Dr. Margarita Guryanova, Department of Chemotherapy of Hematologic Diseases, National medical research center for hematology of the Ministry of Health of Russia, Moscow.

“Preliminary results of the Russian prospective multicenter study on the observation of patients with chronic myeloid leukemia with deep molecular response to therapy with reduced doses of tyrosine kinase inhibitors followed by treatment withdrawal (readit-2020)”

Dr. Anastasia Vinokurova, hematologist of the Department of Hematology and Chemotherapy GBUZ TO OKB № 1, Tyumen.

“Clinical case of treatment of a patient with refractory course of prolymphocytic leukemia”.

2022

Dr. Maria Kislova, 2nd year resident, State Budgetary Healthcare Institution S.P. Botkin Hospital of the Moscow Department of Health, Moscow, Russia

“The Impact of Quarantine on the Incidence of Infections in Patients with Chronic Lymphocytic Leukemia during the COVID-19 Pandemic”.

Dr. Andrei Petrtenko, hematologist, State Budgetary Healthcare Institution S.P. Botkin Hospital of the Moscow Department of Health, Moscow.

“Ibrutinib and Venetoclax in the Treatment of Patients with Chronic Lymphocytic Leukemia and Complex Karyotype”.

Dr. Ludmila Fedorova, PhD-student, R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg

“Prognosis of Patients After Discontinuing Nivolumab Therapy and the Efficacy of Retreatment in Patients with Refractory and Relapsed Classical Hodgkin Lymphoma”.